AOK NORDWEST Die Gesundheitskasse Tender

Contract notice: open house contracts for several active ingredients The subject of this publication is the conclusion of contracts in accordance with section 130a para. 8 sgb v on the following active ingredients within the framework of a so-called open-house procedure: deferasirox (v03ac03) distigmin (n07aa03) everolimus (l04aa18) fampridine (n07xx07) lanthanum (iii) carbonate (v03ae03) only in the form of chewable tablets, as well as a single dosage form all suitable and interested pharmaceutical companies or associations of pharmaceutical companies are able to conclude a discount agreement in accordance with section 130a para. 8 sgb v. the earliest contract start is 01.03.2022. based on this, the contract term is a maximum of 24 months.Subject to uniform contractual conditions and a uniform access procedure, all suitable and interested pharmaceutical companies or associations of pharmaceutical companies can conclude a discount agreement in accordance with section 130a para. 8 sgb v. the earliest contract start is 01.03.2022. based on this, the contract term is a maximum of 24 months.